Risk factors of pain in breast cancer survivors: a systematic review and meta-analysis

Supportive Care in Cancer

Volumn 25, Issue 12, 2017, Pages 3607-3643

  Leysen, Laurence ^a,b   Beckwée, David ^b,c   Nijs, Jo ^a,b,d   Pas, Roselien ^a,b   Bilterys, Thomas ^b   Vermeir, Sofie ^b   Adriaenssens, Nele ^b,d  

^a Pain in Motion International Research Group   (Belgium)

^b VRIJE UNIVERSITEIT BRUSSEL   (Belgium)

^c UNIVERSITY OF ANTWERP   (Belgium)

^d UNIVERSITY HOSPITAL BRUSSELS   (Belgium)

Author keywords

Breast cancer survivor; Chronic pain; Pain; Risk factors

Indexed keywords

ANTINEOPLASTIC AGENT; HORMONE RECEPTOR;

AGE; AXILLARY LYMPH NODE; BODY MASS; BREAST CANCER; CANCER CHEMOTHERAPY; CANCER HORMONE THERAPY; CANCER PAIN; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURVIVOR; CHRONIC PAIN; COMORBIDITY; EDUCATION; HUMAN; LYMPH NODE DISSECTION; LYMPHEDEMA; MASTALGIA; MASTECTOMY; MEDLINE; META ANALYSIS; PARTIAL MASTECTOMY; PRIORITY JOURNAL; REVIEW; RISK FACTOR; SENTINEL LYMPH NODE BIOPSY; SMOKING; SYSTEMATIC REVIEW; WEB OF SCIENCE; AGED; BREAST TUMOR; CLINICAL TRIAL; FEMALE; INCIDENCE; MIDDLE AGED; MORTALITY; MULTICENTER STUDY; PAIN; PATHOLOGY; PSYCHOLOGY;

AGED; BREAST NEOPLASMS; CANCER SURVIVORS; FEMALE; HUMANS; INCIDENCE; MASTECTOMY; MIDDLE AGED; PAIN; RISK FACTORS;

EID: 85027171842     PISSN: 09414355     EISSN: 14337339     Source Type: Journal    
DOI: 10.1007/s00520-017-3824-3     Document Type: Review

References (64)

1. Ferlay J et al (2015) Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer 136(5):E359–E386
2. Ferlay J et al (2010) Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer 127(12):2893–2917
3. Katanoda K, Matsuda T (2014) Five-year relative survival rate of breast cancer in the USA, Europe and Japan. Jpn J Clin Oncol 44(6):611
4. Organization, W.H., World cancer report 2014. 2014, Lyonn, France: International Agency for Research on Cancer.
5. Befort CA, Klemp J (2011) Sequelae of breast cancer and the influence of menopausal status at diagnosis among rural breast cancer survivors. J Women's Health 20(9):1307–1313
6. Glare PA et al (2014) Pain in cancer survivors. J Clin Oncol 32(16):1739–1747
7. Forsythe LP et al (2013) Pain in long-term breast cancer survivors: The role of body mass index, physical activity, and sedentary behavior. Breast Cancer Res Treat 137(2):617–630
8. Pain, I.A.f.t.S.o. Pain, IASP Taxonomy. 2014 2014–10-06 [cited 2016 2016–03-26]; Available from: http://www.iasp-pain.org/Taxonomy - Pain.
9. Merskey, H. and N. Bogduk, Eds. Classification of chronic pain: descriptions of chronic pain syndromes and definitions of pain terms. Second edition ed. 1994, IASP Press: Seattle
10. Chang SH, Metha V, Langford R (2009) Acute and chronic pain following breast surgery. Acute Pain 11(1):1–14
11. Andersen KG, Kehlet H (2011) Persistent pain after breast cancer treatment: A critical review of risk factors and strategies for prevention. J Pain 12(7):725–746
12. Liberati A et al (2009) The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: Explanation and elaboration. J Clin Epidemiol 62(10):e1–34
13. NCI, O.o.C.S., About Cancer Survivorship Research: Survivorship Definitions. 2012, Washington, DC
14. Elmagarmid, A., et al., Rayyan: a systematic reviews web app for exploring and filtering searches for eligible studies for Cochrane Reviews., in Evidence-Informed Public Health: Opportunities and Challenges. Abstracts of the 22nd Cochrane Colloquium. 2014, John Wiley & sons: Hyderabad, India
15. Bredal IS et al (2014) Chronic pain in breast cancer survivors: Comparison of psychosocial, surgical, and medical characteristics between survivors with and without pain. J Pain Symptom Manag 48(5):852–862
16. Moloney N et al (2016) Prevalence and risk factors associated with pain 21 months following surgery for breast cancer. Support Care Cancer 24(11):4533–4539
17. Steyaert A et al (2016) Does the perioperative analgesic/anesthetic regimen influence the prevalence of long-term chronic pain after mastectomy? J Clin Anesth 33:20–25
18. von Elm E et al (2014) The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) Statement: guidelines for reporting observational studies. Int J Surg (London, England) 12(12):1495–1499
19. Higgins JP et al (2003) Measuring inconsistency in meta-analyses. BMJ 327(7414):557–560
20. Higgins, J.P.T. and S. Green, Cochrane Handbook for Systematic Reviews of Interventions. Version 5.0.1 [updated September 2008]. Chapter 9: Analysing data and undertaking meta-analyses., ed. J.J. Deeks, J.P.T. Higgins, and D.G. Altman. 2008: The Cochrane Collaboration.
21. Johannsen M et al (2015) Socio-demographic, treatment-related, and health behavioral predictors of persistent pain 15 months and 7-9 years after surgery: A nationwide prospective study of women treated for primary breast cancer. Breast Cancer Res Treat 152(3):645–658
22. Peuckmann V et al (2009) Chronic pain and other sequelae in long-term breast cancer survivors: Nationwide survey in Denmark. Eur J Pain 13(5):478–485
23. Romero A et al (2016) Prevalence of persistent pain after breast cancer treatment by detection mode among participants in population-based screening programs. BMC Cancer 16
24. Andersen Juhl A, Christiansen P, Damsgaard TE (2016) Persistent pain after breast cancer treatment: A questionnaire-based study on the prevalence, associated treatment variables, and pain type. J Breast Cancer 19(4):447–454
25. Alkan A et al (2016) Breast cancer survivors suffer from persistent postmastectomy pain syndrome and posttraumatic stress disorder (ORTHUS study): A study of the palliative care working committee of the Turkish oncology group (TOG). Support Care Cancer 24(9):3747–3755
26. Lundstedt D et al (2015) Radiation therapy to the plexus brachialis in breast cancer patients: Analysis of paresthesia in relation to dose and volume. Int J Radiat Oncol Biol Phys 92(2):277–283
27. Bantema-Joppe EJ et al (2012) Simultaneous integrated boost irradiation after breast-conserving surgery: Physician-rated toxicity and cosmetic outcome at 30 months' follow-up. Int J Radiat Oncol Biol Phys 83(4):e471–e477
28. Bell RJ et al (2014) Persistent breast pain 5 years after treatment of invasive breast cancer is largely unexplained by factors associated with treatment. J Cancer Surviv 8(1):1–8
29. Gulluoglu BM et al (2006) Factors related to post-treatment chronic pain in breast cancer survivors: The interference of pain with life functions. Int J Fertil Womens Med 51(2):75–82
30. Calhoun C, Helzlsouer KJ, Gallicchio L (2015) Racial differences in depressive symptoms and self-rated health among breast cancer survivors on aromatase inhibitor therapy. J Psychosoc Oncol 33(3):263–277
31. Crandall C et al (2004) Association of breast cancer and its therapy with menopause-related symptoms. Menopause- J North Am Menopause Soc 11(5):519–530
32. van Londen GJ et al (2014) Associations between adjuvant endocrine therapy and onset of physical and emotional concerns among breast cancer survivors. Support Care Cancer 22(4):937–945
33. Lundstedt D et al (2010) Symptoms 10-17 years after breast cancer radiotherapy data from the randomised SWEBCG91-RT trial. Radiother Oncol 97(2):281–287
34. Crandall C et al (2004) Association of breast cancer and its therapy with menopause-related symptoms. Menopause 11(5):519–530
35. Bell RJ et al (2014) Persistent breast pain 5 years after treatment of invasive breast cancer is largely unexplained by factors associated with treatment. Journal of Cancer Survivorship 8(1):1–8
36. Berrios-Rivera R, Rivero-Vergine A, Romero I (2008) The pediatric cancer hospitalization experience: Reality co-constructed. J Pediatr Oncol Nurs 25(6):340–353
37. Kim SJ, Park YD (2008) Effects of complex decongestive physiotherapy on the oedema and the quality of life of lower unilateral lymphoedema following treatment for gynecological cancer. Eur J Cancer Care (Engl) 17(5):463–468
38. Jeong HJ et al (2011) Causes of shoulder pain in women with breast cancer-related lymphedema: A pilot study. Yonsei Med J 52(4):661–667
39. Taylor RJ et al (2014) Pain and obesity in the older adult. Curr Pharm Des 20(38):6037–6041
40. Okifuji A, Hare BD (2015) The association between chronic pain and obesity. J Pain Res 14(8):399–408
41. Piper, M., et al (2016), Axillary Web Syndrome: Current Understanding and New Directions for Treatment. Ann Plast Surg
42. Yeung WM, McPhail SM, Kuys SS (2015) A systematic review of axillary web syndrome (AWS). J Cancer Surviv 9(4):576–598
43. Cregg R, Anwar S, Farquhar-Smith P (2013) Persistent postsurgical pain. Curr Opin Support Palliat Care 7(2):144–152
44. Shipton EA (2011) The transition from acute to chronic post surgical pain. Anaesth Intensive Care 39(5):824–836
45. Delanian S, Lefaix JL, Pradat PF (2012) Radiation-induced neuropathy in cancer survivors. Radiother Oncol 105(3):273–282
46. Grisold W, Cavaletti G, Windebank AJ (2012) Peripheral neuropathies from chemotherapeutics and targeted agents: Diagnosis, treatment, and prevention. Neuro-Oncology 14:45–54
47. Bhagra A, Rao RD (2007) Chemotherapy-induced neuropathy. Curr Oncol Rep 9(4):290–299
48. Boland EG et al (2014) Central pain processing in chronic chemotherapy-induced peripheral neuropathy: A functional magnetic resonance imaging study. PLoS One 9(5):e96474
49. Lee E et al (2016) Characterization of risk factors for adjuvant radiotherapy-associated pain in a tri-racial/ethnic breast cancer population. Pain 157(5):1122–1131
50. Burton AW et al (2007) Chronic pain in the cancer survivor: A new frontier. Pain Med 8(2):189–198
51. Levy MH, Chwistek M, Mehta RS (2008) Management of chronic pain in cancer survivors. Cancer J 14(6):401–9
52. Altundag K, Ibrahim NK (2006) Aromatase inhibitors in breast cancer: An overview. Oncologist 11(6):553–562
53. Mao JJ et al (2009) Patterns and risk factors associated with aromatase inhibitor-related arthralgia among breast cancer survivors. Cancer 115(16):3631–3639
54. Beckwee, D., et al. (2017) Prevalence of aromatase inhibitor-induced arthralgia in breast cancer: A systematic review and meta-analysis. Support Care Cancer
55. Howell A et al (2005) Results of the ATAC (Arimidex, tamoxifen, alone or in combination) trial after completion of 5 years' adjuvant treatment for breast cancer. Lancet 365(9453):60–62
56. Goss PE et al (2003) A randomized trial of letrozole in postmenopausal women after five years of tamoxifen therapy for early-stage breast cancer. N Engl J Med 349(19):1793–1802
57. Jakesz R et al (2005) Switching of postmenopausal women with endocrine-responsive early breast cancer to anastrozole after 2 years' adjuvant tamoxifen: Combined results of ABCSG trial 8 and ARNO 95 trial. Lancet 366(9484):455–462
58. Burstein HJ (2007) Aromatase inhibitor-associated arthralgia syndrome. Breast 16(3):223–234
59. Peppone LJ et al (2015) The effect of YOCAS(c)((R)) yoga for musculoskeletal symptoms among breast cancer survivors on hormonal therapy. Breast Cancer Res Treat 150(3):597–604
60. Hershman DL, Loprinzi C, Schneider BP (2015) Symptoms: Aromatase inhibitor induced Arthralgias. Adv Exp Med Biol 862:89–100
61. Fusi C et al (2014) Steroidal and non-steroidal third-generation aromatase inhibitors induce pain-like symptoms via TRPA1. Nat Commun 5:5736
62. Turk DC, Wilson HD (2010) Fear of pain as a prognostic factor in chronic pain: Conceptual models, assessment, and treatment implications. Curr Pain Headache Rep 14(2):88–95
63. Boersma K, Linton SJ (2005) Screening to identify patients at risk: Profiles of psychological risk factors for early intervention. Clin J Pain 21(1):38–43
64. Rashiq S, Dick BD (2014) Post-surgical pain syndromes: A review for the non-pain specialist. Can J Anesth 61(2):123–130